Article Information
History
- April 15, 2019.
Article Versions
- You are currently viewing Version 1 of this article (April 15, 2019 - 23:55).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Mayank Vermaa,b,c,d,
- Yuko Shimizu-Motohashib,c,d,
- Yoko Asakurab,c,d,
- James Ennenb,c,d,
- Jennifer Boscof,
- Zhiwei Zouf,
- Guo-Hua Fonge,
- Serene Josiahf,
- Dennis Keefef and
- Atsushi Asakurab,c,d,g
- aMedical Scientist Training Program, University of Minnesota Medical School. Minneapolis, MN, USA
- bStem Cell Institute, University of Minnesota Medical School. Minneapolis, MN, USA
- cPaul & Sheila Wellstone Muscular Dystrophy Center, University of Minnesota Medical School. Minneapolis, MN, USA
- dDepartment of Neurology, University of Minnesota Medical School. Minneapolis, MN, USA
- eCenter for Vascular Biology, University of Connecticut Health Center, University of Connecticut School of Medicine, Farmington, CT, USA
- fShire Human Genetic Therapies(HGT), Lexington, MA, USA, a member of the Takeda group of companies..
- ↵gCorresponding Author:
Atsushi Asakura (asakura{at}umn.edu)